Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Dis Esophagus ; 30(10): 1-2, 2017 Oct 01.
Article in English | MEDLINE | ID: mdl-28859393

ABSTRACT

With the development of endoscopic interventions and inspired by the success of peroral endoscopic myotomy (POEM) for the treatment of achalasia, we investigated an old method of direct peroral endoscopic myotomy without a submucosal tunnel for the treatment of achalasia, which we call open peroral endoscopic myotomy (O-POEM). In this study, Clinical success was achieved in the patient after O-POEM. A reduction of LES pressure, Eckardt score, and a timed barium esophagogram were observed during follow-up. There were no severe complications and no recurrences during two months of follow-up. Therefore, open peroral endoscopic myotomy is a feasible and effective endoscopic treatment modality for achalasia. However, long-term outcomes of O-POEM requires further follow-up.


Subject(s)
Endoscopy, Gastrointestinal/methods , Esophageal Achalasia/surgery , Heller Myotomy/methods , Adult , Humans , Male
2.
Eur Rev Med Pharmacol Sci ; 19(5): 857-65, 2015.
Article in English | MEDLINE | ID: mdl-25807440

ABSTRACT

OBJECTIVE: Bone marrow-derived mesenchymal stem cells (MSCs) can serve as a vehicle for gene therapy. FGF2 (basic fibroblast growth factor) is a multifunctional growth factor and exhibits diverse function in different cell types, it also has pleiotropic effects in different tissues and organs, including potent angiogenic effects and an important role in the differentiation and function of the central nervous system. We hypothesized that MSC-based FGF2 gene therapy might be a potential therapeutic approach for lipopolysaccharide (LPS)-induced lung injury. MATERIALS AND METHODS: MSCs were isolated from 6 week-old inbred male mice and transduced with the FGF2 gene, using a lentivirus vector. RESULTS: In the in vivo mouse model, the LPS-induced lung injury was markedly alleviated in the group treated with MSCs carrying FGF2 (MSCs-FGF2), compared with groups treated with MSCs alone. The histopathological index of LPS-induced lung injury was improved after MSCs-based FGF2 gene treatment. The MSCs-FGF2 administration also reduced the level of inflammatory cytokines. CONCLUSIONS: These results suggest that MSCs and FGF2 have a synergistic role in the treatment of LPS-induced lung injury.


Subject(s)
Acute Lung Injury/therapy , Fibroblast Growth Factor 2/genetics , Genetic Therapy/methods , Mesenchymal Stem Cell Transplantation/methods , Acute Lung Injury/chemically induced , Acute Lung Injury/genetics , Animals , Female , Lipopolysaccharides , Male , Mesenchymal Stem Cells/physiology , Mice , Mice, Inbred C57BL , Random Allocation
3.
J Colloid Interface Sci ; 374(1): 34-9, 2012 May 15.
Article in English | MEDLINE | ID: mdl-22369982

ABSTRACT

Iron catalyst films for the growth of carbon nanotube (CNT) arrays are prepared using sol-gel technique during different hydrolytic periods. It is shown that the extent of hydrolysis of the catalyst precursor has strong impacts on the size and density of iron catalyst particles, which distributed on surface of the film. The iron catalysts formed big clusters in the early stage of the hydrolysis, whereas the particle size decreased dramatically to approximate 20 nm when the hydrolytic duration is as long as 150 h. The reaction between the hydrolytic product of ethyl orthosilicate and the iron oxide particles effectively influence the structure of catalysts during the process of annealing precursor films and reducing the iron oxide particles into iron catalysts. We believe that the hydrolytic product limits the mobility of the catalyst particles, preventing them from aggregating into big clusters by Ostwald ripening. This catalyst film may be utilized to create a template to control the length and quality of CNTs.

4.
Neoplasma ; 58(5): 449-54, 2011.
Article in English | MEDLINE | ID: mdl-21745000

ABSTRACT

CD147, a widely expressed cell surface glycoprotein in cancer, is associated with tumor invasiveness and chemotherapy resistance. Recently, CD147 is also regarded as a potential therapeutic target for cancer therapy. The aim of the study was to investigate CD147 expression in non-small cell lung cancer (NSCLC), and evaluate its correlation with cisplatin-based chemotherapy resistance. In this study, we examined immunohistochemically the expression of CD147 in 118 advanced NSCLC cases treated with cisplatin-based chemotherapy, and then the association of CD147 expression with clinicopathological characteristics was analyzed. Furthermore, RNA interference approach was used to silence CD147 expression in a cisplatin-resistant human lung cancer cell line A549/DDP, and the inhibition effect of cisplatin on tumor cells was assayed by MTT. In the overall series, positive CD147 expression was observed in 101/118 (85.6%) cases. A membranous CD147 pattern was identified in 76/101 (75.2%) of CD147 positive tumors. CD147 membranous expression,but not the overall CD147 expression, was associated with poor response to cisplatin-based chemotherapies and a poor prognosis in advanced NSCLC patients. In vitro results showed that silencing CD147 increased the proliferation inhibitory effect of cisplatin to A549/DDP cells. In conclusion, our study indicated that membranous CD147 expression is a predictive factor of the response to cisplatin-based chemotherapies, and the use of CD147-targeted therapeutic adjuvants might be considered in the treatment of advanced NSCLC patients.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Basigin/metabolism , Carcinoma, Non-Small-Cell Lung/drug therapy , Carcinoma, Non-Small-Cell Lung/metabolism , Cell Proliferation/drug effects , Drug Resistance, Neoplasm , Adenocarcinoma/drug therapy , Adenocarcinoma/metabolism , Adenocarcinoma/pathology , Carcinoma, Non-Small-Cell Lung/pathology , Carcinoma, Squamous Cell/drug therapy , Carcinoma, Squamous Cell/metabolism , Carcinoma, Squamous Cell/pathology , Cell Line, Tumor , Cell Membrane/metabolism , Cisplatin/administration & dosage , Deoxycytidine/administration & dosage , Deoxycytidine/analogs & derivatives , Female , Humans , Immunoenzyme Techniques , Lung Neoplasms/drug therapy , Lung Neoplasms/metabolism , Lung Neoplasms/pathology , Male , Middle Aged , Paclitaxel/administration & dosage , Survival Rate , Treatment Outcome , Vinblastine/administration & dosage , Vinblastine/analogs & derivatives , Vinorelbine , Gemcitabine
5.
J Nanosci Nanotechnol ; 11(12): 11227-30, 2011 Dec.
Article in English | MEDLINE | ID: mdl-22409090

ABSTRACT

In this paper, the "sandwich" structured magnetoelectric composite films of Pb(Zr0.52Ti0.48)O3/ NiFe2O4/Pb(Zr0.52Ti0.48)O3 and Pb(Zr0.52Ti0.48)O3/CoFe2O4/Pb(Zr0.52Ti0.48)O3 are epitaxially grown on SrRuO3/SrTiO3 substrates by pulsed-laser deposition. The crystalline quality and microstructures of these heterostructures are investigated by X-ray diffraction technique. The effects of strain on the ferroelectric, magnetic and magnetoelectric coupling properties of these thin films are systematically studied. The results show that the strain effect induced by lattice mismatch between the ferroelectric/ferromagnetic layers plays an important role in the ferroelectric and magnetic properties of these composite films. Compared to the strained Pb(Zr0.52Ti0.48)O3/ CoFe2O4/Pb(Zr0.52Ti0.48)O3 heterostructure, improved ferroelectric properties with an out-of-plane polarization (2P(r)) of 34.2 microC/cm2 and electric coercivity field of 158 kV/cm are obtained in the strain-free Pb(Zr0.52Ti0.48)O3/NiFe2O4/Pb(Zr0.52Ti0.48)O3 heterostructure. The ME measurement results not only show that the strain induced by lattice mismatch has great influence on the ME behavior, but also provide an understanding of the multilayers with full control over the interface structure at the atomic-scale.

SELECTION OF CITATIONS
SEARCH DETAIL
...